VANCOUVER, British Columbia, June 05, 2026 (GLOBE NEWSWIRE) — Alzai Health Corp. (“Alzai” or the “Corporation”), further to its press release dated April 22, 2026, is pleased to announce that, pursuant to a bulletin to be issued by the TSX Venture Exchange (the “TSXV” or the “Exchange”) on June 5, 2026, the Corporation has now met all final listing requirements of the Exchange, assuming closing of the previously announced initial public offering of a minimum of 8,000,000 units of the Corporation (the “Units”) and a maximum of 10,000,000 Units at a price of $0.40 per Unit for gross proceeds of a minimum of $3,200,000 and a maximum of $4,000,000 (the “Offering”). The Corporation has granted Haywood Securities Inc. (the “Agent”) an option, exercisable in whole or in part, by the Agent giving written notice to the Corporation at any time up to 48 hours prior to the closing date of the Offering, to sell up to an additional 15% of the Units sold under the Offering (the “Additional Units”). The Additional Units will have the same terms as the Units.